The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
Year: 2010
Type: review
Authors: Mario Cazzola, Mathieu Molimard
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Novartis, Sanofi, Novartis Pharma
OpenAlex ID: W2003293665
